February Issue of “Glioma” Highlights Positive Progression-Free Survival Data SAN DIEGO, Jan. 29, 2020 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development… Read More
Dr. Chonnettia Jones, a respected scientist with extensive health research funding experience, joins MSFHR as vice president, research effective April 14, 2020. In her role, Chonnettia will lead our funding… Read More
VANCOUVER, British Columbia, Jan. 28, 2020 (GLOBE NEWSWIRE) — Quark Venture LP and GF Securities participated in the $22 million Series C financing announced in December 2019 for Raziel Therapeutics… Read More
Vancouver, BC – January 21, 2020 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing medications targeting diseases with high unmet medical need… Read More
Vancouver, BC – January 20, 2020 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing therapeutics targeting diseases with high unmet medical needs,… Read More
